ABE1972
Anti-Ash2L Antibody
serum, from rabbit
Synonym(e):
Set1/Ash2 histone methyltransferase complex subunit ASH2, ASH2-like protein
About This Item
Empfohlene Produkte
Biologische Quelle
rabbit
Qualitätsniveau
Antikörperform
serum
Antikörper-Produkttyp
primary antibodies
Klon
polyclonal
Speziesreaktivität
mouse, human
Methode(n)
ChIP: suitable
immunoprecipitation (IP): suitable
western blot: suitable
NCBI-Hinterlegungsnummer
UniProt-Hinterlegungsnummer
Versandbedingung
ambient
Posttranslationale Modifikation Target
unmodified
Angaben zum Gen
human ... ASH2L(9070)
Allgemeine Beschreibung
Spezifität
Immunogen
Anwendung
Epigenetik & nukleäre Funktionen
Immunoprecipitation Analysis: A representative lot co-immunoprecipitated Mef2 with Ash2L from nuclear extract of differentiating C2C12 murine myoblasts (Rampalli, S., et al. (2007). Nat. Struct. Mol. Biol. 14(12):1150-1156).
Western Blotting Analysis: A representative lot detected full-length as well as N-terminal (a.a. 96 281) and C-terminal (a.a. 317-628) recombinant human Ash2L constructs. Full-length and the C-terminal fragment, but not the N-terminal fragment, were detected in the pull-down by GST-tagged RbBP5 (Avdic, V., et al. (2011). Structure. 19(1):101-108).
Western Blotting Analysis: A representative lot detected Ash2L in Mef2, MLL1, MLL2, MLL3, MLL4, and SET1 immunoprecipitates from differentiating C2C12 murine myoblasts. Ash2L in Mef2 IP was greatly reduced when using lysates from MAP kinase p38 inhibitor-treated cells (Rampalli, S., et al. (2007). Nat. Struct. Mol. Biol. 14(12):1150-1156).
Western Blotting Analysis: A representative lot detected an increased Ash2L pull-down from nuclear extract of differentiating C2C12 murine myoblasts by FLAG-tagged Mef2c and Mef2d following their phosphorylation by p38alpha, while no Ash2L pull-down was seen by Mef2d p38 phosphorylation sites mutatant (Rampalli, S., et al. (2007). Nat. Struct. Mol. Biol. 14(12):1150-1156).
Western Blotting Analysis: A representative lot detected Ash2L in whole cell lysate and nuclear extract, but not cytosolic extract from differentiating C2C12 murine myoblasts, Ash2L shRNA treatment dercreased target band intensity (Rampalli, S., et al. (2007). Nat. Struct. Mol. Biol. 14(12):1150-1156).
Qualität
Western Blotting Analysis: A 1:1,000 dilution of this antiserum detected Ash2L in 10 µg of C2C12 murine myoblast lysate.
Zielbeschreibung
Physikalische Form
Lagerung und Haltbarkeit
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Sonstige Hinweise
Haftungsausschluss
Not finding the right product?
Try our Produkt-Auswahlhilfe.
Lagerklassenschlüssel
12 - Non Combustible Liquids
WGK
WGK 1
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.